{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:25:17Z","timestamp":1759991117660},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"ANRS (French Agency for Research on AIDS and Viral Hepatitis)"},{"name":"French National Agency for Research for AIDS and Viral Hepatitis (ANRS)"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ijdp.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.drugpo.2018.06.013","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T13:17:45Z","timestamp":1530191865000},"page":"3-9","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Profile, risk practices and needs of people who inject morphine sulfate: Results from the ANRS-AERLI study"],"prefix":"10.1016","volume":"59","author":[{"given":"Perrine","family":"Roux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Mezaache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"La\u00e9lia","family":"Briand-Madrid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Debrus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Khatmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwenaelle","family":"Maradan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cam\u00e9lia","family":"Protopopescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Rojas-Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Carrieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.drugpo.2018.06.013_bib0005","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1080\/10550490490440780","article-title":"French field experience with buprenorphine","volume":"13","author":"Auriacombe","year":"2004","journal-title":"American Journal On Addictions"},{"issue":"4","key":"10.1016\/j.drugpo.2018.06.013_bib0010","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/add.12440","article-title":"Maintenance treatment for opioid dependence with slow-release oral morphine: A randomized cross-over, non-inferiority study versus methadone","volume":"109","author":"Beck","year":"2014","journal-title":"Addiction"},{"issue":"7","key":"10.1016\/j.drugpo.2018.06.013_bib0015","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1530-0277.2007.00403.x","article-title":"AUDIT-C as a brief screen for alcohol misuse in primary care","volume":"31","author":"Bradley","year":"2007","journal-title":"Alcoholism: Clinical And Experimental Research"},{"key":"10.1016\/j.drugpo.2018.06.013_bib0020","first-page":"2012","article-title":"L\u2019usage du sulfate de morphine par les usagers de drogues en France","author":"Cadet-Ta\u00efrou","year":"2014","journal-title":"Tendances R\u00e9centes"},{"issue":"Suppl 4","key":"10.1016\/j.drugpo.2018.06.013_bib0025","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1086\/508184","article-title":"Buprenorphine use: The international experience","volume":"43","author":"Carrieri","year":"2006","journal-title":"Clinical Infectious Diseases"},{"issue":"11","key":"10.1016\/j.drugpo.2018.06.013_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112328","article-title":"Methadone induction in primary care for opioid dependence: A pragmatic randomized trial (ANRS Methaville)","volume":"9","author":"Carrieri","year":"2014","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.drugpo.2018.06.013_bib0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.pharma.2009.06.001","article-title":"[Opiate substitution: The users\u2019 point of view]","volume":"67","author":"Chappard","year":"2009","journal-title":"Annales Pharmaceutiques Francaises"},{"key":"10.1016\/j.drugpo.2018.06.013_bib0040","unstructured":"Circulaire n\u00b054 du 5 ao\u00fbt 1996 relative \u00e0 la prise en charge des traitements de substitution \u00e0 base de sulfate de morphine pour les toxicomanes, (1996)."},{"issue":"1","key":"10.1016\/j.drugpo.2018.06.013_bib0045","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11096-015-0223-z","article-title":"Development of a decision support system for the practice of responsible self-medication","volume":"38","author":"da Rocha","year":"2016","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"10.1016\/j.drugpo.2018.06.013_bib0050","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0376-8716(98)00028-3","article-title":"Self-report among injecting drug users: A review","volume":"51","author":"Darke","year":"1998","journal-title":"Drug And Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.drugpo.2018.06.013_bib0055","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1360-0443.1992.tb02719.x","article-title":"Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: The opiate treatment index","volume":"87","author":"Darke","year":"1992","journal-title":"British Journal Of Addiction"},{"issue":"1","key":"10.1016\/j.drugpo.2018.06.013_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2004.05607.x","article-title":"Cutaneous complications of intravenous drug abuse","volume":"150","author":"Del Giudice","year":"2004","journal-title":"British Journal Of Dermatology"},{"key":"10.1016\/j.drugpo.2018.06.013_bib0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.drugalcdep.2016.02.035","article-title":"Incidence of high dosage buprenorphine and methadone shopping behavior in a retrospective cohort of opioid-maintained patients in France","volume":"162","author":"Delorme","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.drugpo.2018.06.013_bib0070","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2515\/therapie\/2013073","article-title":"[Necrotizing fasciitis related to injections of morphine (Skenan((R))) in a HIV-infected patient]","volume":"69","author":"Diot","year":"2014","journal-title":"Therapie"},{"issue":"1-2","key":"10.1016\/j.drugpo.2018.06.013_bib0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugalcdep.2008.08.016","article-title":"Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users","volume":"100","author":"Dwyer","year":"2009","journal-title":"Drug And Alcohol Dependence"},{"issue":"8","key":"10.1016\/j.drugpo.2018.06.013_bib0080","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1360-0443.2005.001128.x","article-title":"Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy","volume":"100","author":"Eder","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2018.06.013_bib0085","series-title":"Year of introduction of methadone maintenance treatment, high-dosage buprenorphine treatment, buprenorphine\/naloxone combination, heroin-assisted treatment and slow-release morphine","author":"EMCDDA","year":"2012"},{"issue":"2","key":"10.1016\/j.drugpo.2018.06.013_bib0090","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/JCP.0000000000000288","article-title":"Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: A randomized, crossover clinical trial","volume":"35","author":"Falcato","year":"2015","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2","key":"10.1016\/j.drugpo.2018.06.013_bib0095","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1360-0443.1999.9422317.x","article-title":"Comparison of methadone and slow-release morphine maintenance in pregnant addicts","volume":"94","author":"Fischer","year":"1999","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.drugpo.2018.06.013_bib0100","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1360-0443.2003.00207.x","article-title":"Psychometric properties of the blood-borne virus transmission risk assessment questionnaire (BBV-TRAQ)","volume":"98","author":"Fry","year":"2003","journal-title":"Addiction"},{"issue":"18","key":"10.1016\/j.drugpo.2018.06.013_bib0105","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMra042823","article-title":"Bacterial infections in drug users","volume":"353","author":"Gordon","year":"2005","journal-title":"The New England Journal Of Medicine"},{"issue":"4","key":"10.1016\/j.drugpo.2018.06.013_bib0110","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archpsyc.1978.01770280111012","article-title":"Human pharmacology and abuse potential of the analgesic buprenorphine: A potential agent for treating narcotic addiction","volume":"35","author":"Jasinski","year":"1978","journal-title":"Archives Of General Psychiatry"},{"issue":"1","key":"10.1016\/j.drugpo.2018.06.013_bib0115","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/pubmed\/fdh189","article-title":"High rates of primary care and emergency department use among injection drug users in vancouver","volume":"27","author":"Kerr","year":"2005","journal-title":"Journal of Public Health (Oxf)"},{"issue":"4","key":"10.1016\/j.drugpo.2018.06.013_bib0120","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/add.12004","article-title":"Addiction as a self-regulation disorder and the role of self-medication","volume":"108","author":"Khantzian","year":"2013","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.drugpo.2018.06.013_bib0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000085550","article-title":"Use of slow-release oral morphine for the treatment of opioid dependence","volume":"11","author":"Kraigher","year":"2005","journal-title":"European Addiction Research"},{"key":"10.1016\/j.drugpo.2018.06.013_bib0130","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.drugalcdep.2015.09.026","article-title":"The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs","volume":"156","author":"Lake","year":"2015","journal-title":"Drug And Alcohol Dependence"},{"issue":"10","key":"10.1016\/j.drugpo.2018.06.013_bib0135","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/jcp.25.10.876","article-title":"Starch and talc emboli in drug addicts\u2019 lungs","volume":"25","author":"Lamb","year":"1972","journal-title":"Journal Of Clinical Pathology"},{"key":"10.1016\/j.drugpo.2018.06.013_bib0140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.drugalcdep.2016.11.029","article-title":"A systematic review of injecting-related injury and disease among people who inject drugs","volume":"171","author":"Larney","year":"2017","journal-title":"Drug And Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.drugpo.2018.06.013_bib0145","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/ADM.0000000000000045","article-title":"A review of buprenorphine diversion and misuse: The current evidence base and experiences from around the world","volume":"8","author":"Lofwall","year":"2014","journal-title":"J Addict Med"},{"issue":"8","key":"10.1016\/j.drugpo.2018.06.013_bib0150","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/j.1360-0443.2004.00764.x","article-title":"Slow-release oral morphine versus methadone: A crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence","volume":"99","author":"Mitchell","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2018.06.013_bib0155","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.drugalcdep.2017.02.021","article-title":"Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder","volume":"176","author":"Oviedo-Joekes","year":"2017","journal-title":"Drug And Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.drugpo.2018.06.013_bib0160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000346179","article-title":"Slow-release oral morphine sulfate abuse: Results of the postmarketing surveillance systems for psychoactive prescription drug abuse in France","volume":"19","author":"Peyriere","year":"2013","journal-title":"European Addiction Research"},{"issue":"5","key":"10.1016\/j.drugpo.2018.06.013_bib0165","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/fcp.12210","article-title":"Evidence of slow-release morphine sulfate abuse and diversion: Epidemiological approaches in a French administrative area","volume":"30","author":"Peyriere","year":"2016","journal-title":"Fundamental & Clinical Pharmacology"},{"key":"10.1016\/j.drugpo.2018.06.013_bib0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3917\/rfas.081.0081","article-title":"Les d\u00e9terminants du recours \u00e0 l\u2019autom\u00e9dication","volume":"1","author":"Raynaud","year":"2008","journal-title":"Revue Fran\u00e7aise Des Affaires Sociales"},{"issue":"4","key":"10.1016\/j.drugpo.2018.06.013_bib0175","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2165\/00003088-200645040-00005","article-title":"Population pharmacokinetics of heroin and its major metabolites","volume":"45","author":"Rook","year":"2006","journal-title":"Clinical Pharmacokinetics"},{"issue":"1","key":"10.1016\/j.drugpo.2018.06.013_bib0180","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/add.13089","article-title":"Innovative community-based educational face-to-face intervention to reduce HIV, hepatitis C virus and other blood-borne infectious risks in difficult-to-reach people who inject drugs: Results from the ANRS-AERLI intervention study","volume":"111","author":"Roux","year":"2016","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.drugpo.2018.06.013_bib0185","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13011-017-0131-4","article-title":"Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: Results from a community-based survey in France","volume":"12","author":"Roux","year":"2017","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"1-2","key":"10.1016\/j.drugpo.2018.06.013_bib0190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugalcdep.2008.03.025","article-title":"Buprenorphine in primary care: Risk factors for treatment injection and implications for clinical management","volume":"97","author":"Roux","year":"2008","journal-title":"Drug And Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.drugpo.2018.06.013_bib0195","first-page":"327","article-title":"Successful lung transplantation for talcosis secondary to intravenous abuse of oral drug","volume":"3","author":"Shlomi","year":"2008","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"1","key":"10.1016\/j.drugpo.2018.06.013_bib0200","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1192\/bjp.bp.114.149195","article-title":"Heroin on trial: Systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addictiondagger","volume":"207","author":"Strang","year":"2015","journal-title":"British Journal Of Psychiatry"},{"key":"10.1016\/j.drugpo.2018.06.013_bib0205","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S2049-0801(12)70013-4","article-title":"NICE opioids in palliative care (clinical guideline 140) - A guideline summary","volume":"1","author":"Teoh","year":"2012","journal-title":"Ann Med Surg (Lond)"},{"issue":"2","key":"10.1016\/j.drugpo.2018.06.013_bib0210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0376-8716(01)00161-2","article-title":"Buprenorphine prescription by general practitioners in a French region","volume":"65","author":"Thirion","year":"2002","journal-title":"Drug And Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.drugpo.2018.06.013_bib0215","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000368572","article-title":"Mental symptoms and drug use in maintenance treatment with slow-release oral morphine compared to methadone: Results of a randomized crossover study","volume":"21","author":"Verthein","year":"2015","journal-title":"European Addiction Research"},{"issue":"1","key":"10.1016\/j.drugpo.2018.06.013_bib0220","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1378\/chest.78.1.90","article-title":"Self-induced pulmonary granulomatosis. A consequence of intravenous injection of drugs intended for oral use","volume":"78","author":"Waller","year":"1980","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.drugpo.2018.06.013_bib0225","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.drugalcdep.2008.05.007","article-title":"The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers","volume":"98","author":"Walsh","year":"2008","journal-title":"Drug And Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.drugpo.2018.06.013_bib0230","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1874473711104010028","article-title":"Buprenorphine and buprenorphine\/naloxone diversion, misuse, and illicit use: an international review","volume":"4","author":"Yokell","year":"2011","journal-title":"Curr Drug Abuse Rev"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395918301750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395918301750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T15:21:08Z","timestamp":1604503268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395918301750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":46,"alternative-id":["S0955395918301750"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2018.06.013","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profile, risk practices and needs of people who inject morphine sulfate: Results from the ANRS-AERLI study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2018.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}